New insights into predicting myeloma drug response
Summary
Although patients with the same cancer diagnosis may respond very differently to treatment, clinicians still have limited tools at their disposal to predict who is most likely to benefit or suffer from a particular myeloma therapy.
Description
Although patients with the same cancer diagnosis may respond very differently to treatment, clinicians still have limited tools at their disposal to predict who is most likely to benefit or suffer from a particular myeloma therapy.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source